Important Note This content is intended for educational and research purposes only and does not constitute medical advice, diagnosis, or treatment
JPMorgan last year said that current GLP-1 users purchased around 8% less food including snacks, soft drinks and high-carb products over the prior year, compared with consumers who were not on these drugs
In the SURPASS 1-5 trials, different dosages of Tirzepatide (5 mg, 10 mg, and 15 mg) demonstrated significant weight reduction in obese patients with type 2 diabetes mellitus (T2DM), especially when compared to placebo (SURPASS 1) (25), semaglutide 1 mg (SURPASS 2) (26), insulin degludec (SURPASS 3) (27), insulin glargine (SURPASS 4) (28), and placebo+ insulin glargine (SURPASS 5) (29)
Adaptogens have been used for centuries as part of Chinese medicine treatments
The advantages of telehealth For people paying out of pocket, telehealth can offer a more predictable way to access prescription weight management care
16 Diabetes Control Complications Trial Research GroupNathanDMGenuthSLachinJClearyPCroffordOet al
